◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Dr. Lal PathLabs Limited (LALPATHLAB)
来自官方财务报表的收入、利润与现金流历史。
Healthcare · 华尔街（美国） · 最近更新： 2026-09-20
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
关键数据
- 市值: ₹317 billion
- 收入（截至 2026-03-31 财年）: ₹27.6B
- 净利润: ₹5.0B
- 毛利率: 80.6%
- 净利率: 18.3%
查看交互式图表与完整报表 →
年度利润表
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|
| 总收入 | ₹27.6B | ₹24.6B | ₹22.3B | ₹20.2B |
| 毛利 | ₹22.3B | ₹19.8B | ₹14.6B | ₹12.9B |
| 营业利润（EBIT） | ₹10.2B | ₹9.0B | ₹4.7B | ₹3.4B |
| 净利 | ₹5.0B | ₹4.9B | ₹3.6B | ₹2.4B |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 LALPATHLAB 交互式查看器。 /companies/us/LALPATHLAB
类似公司
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.